Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Langmuir

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|December 14, 2011
Vandetanib for the treatment of thyroid cancerP B Langmuir, A Yver
Best Practice & Research. Clinical Haematology|May 18, 2001
Acute myeloid leukaemia in childrenP B Langmuir, R Aplenc, B J Lange
Blood|January 29, 2000
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cellsA Guerriero, P B Langmuir, L M Spain, et al.
International Immunology|February 1, 1993
Bone marrow abnormalities in the non-obese diabetic mouseP B Langmuir, M M Bridgett, A L Bothwell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old questionE J Suchin, P B Langmuir, E Palmer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|December 14, 2011
Vandetanib for the treatment of thyroid cancerP B Langmuir, A Yver
Best Practice & Research. Clinical Haematology|May 18, 2001
Acute myeloid leukaemia in childrenP B Langmuir, R Aplenc, B J Lange
Blood|January 29, 2000
PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cellsA Guerriero, P B Langmuir, L M Spain, et al.
International Immunology|February 1, 1993
Bone marrow abnormalities in the non-obese diabetic mouseP B Langmuir, M M Bridgett, A L Bothwell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old questionE J Suchin, P B Langmuir, E Palmer, et al.
Pageof 1